Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients — Stella

Home/Cytomegalovirus Infections/

View on ClinicalTrials.gov

Recruiting

Back to Cytomegalovirus Infections trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

UW Hospital and Clinics, Madison, Wisconsin

Key details

Phase

Large-scale testing

Sponsor

University of Wisconsin, Madison

Collaborators

Merck Sharp & Dohme LLC

Enrollment target

~90 participants

Started

August 2024

Primary completion

September 2026

Age range

18 Years and older

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.